newsfilter
← Earnings
Earnings Releases·

Stereotaxis — Q3 2026 Earnings Summary

Stereotaxis reported third-quarter 2026 revenue of $8.9 million, representing a 20% increase from the prior year, driven by a 60% rise in system sales to $3 million. The company recorded a net loss of $6.5 million, with operating expenses totaling $10.4 million due to the absorption of Robocath and one-time acquisition costs. At the end of the quarter, cash and cash equivalents stood at $4.0 million, though the company announced a convertible note financing of up to $24 million to bolster liquidity. Management expects recurring revenue growth and stable operating expenses to lead to cash-flow profitability within the next year.

Company
STEREOTAXIS INC
Sector
Healthcare
Industry
Medical Instruments & Supplies